Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
ProQR Therapeutics N.V.
13G/A
Amendment 1
PRQR · N71542109
|
5.2% |
7/15/2026
Event 7/15/2026
|
|||
| Stichting Aescap Life Sciences | 3.0% | ||||
| Privium Fund Management B.V. | 3.9% | ||||
| Stichting Aescap Genetics | 0.9% | ||||
| Inspirational Visions B.V. | <0.1% | ||||
| Patrick Johan Hendrik Krol | 5.2% | ||||
|
ProQR Therapeutics N.V.
13G
PRQR · N71542109
|
5.2% |
1/20/2026
Event 12/11/2025
|
|||
| Stichting Aescap Life Sciences | 3.9% | ||||
| Privium Fund Management B.V. | 5.2% | ||||
| Stichting Aescap Genetics | 1.2% | ||||
| Inspirational Visions B.V. | 0.1% | ||||
| Patrick Johan Hendrik Krol | 5.2% | ||||